SBTX.L Stock - SkinBioTherapeutics Plc
Unlock GoAI Insights for SBTX.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.64M | $1.21M | $132,057 | $74,761 | N/A |
| Gross Profit | $2.71M | $683,038 | $85,190 | $45,337 | $-5,055 |
| Gross Margin | 58.3% | 56.5% | 64.5% | 60.6% | N/A |
| Operating Income | $-826,786 | $-2,905,000 | $-2,999,352 | $-2,982,088 | $-1,494,350 |
| Net Income | $-696,253 | $-2,876,000 | $-2,835,149 | $-2,792,601 | $-1,432,969 |
| Net Margin | -15.0% | -237.9% | -2146.9% | -3735.4% | N/A |
| EPS | $-0.00 | $-0.02 | $-0.02 | $-0.02 | $-0.01 |
SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health. The company develops SkinBiotix technology that can enhance the barrier effect of skin models, protect skin from infections, and repair wounds; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company has a collaboration agreement with Croda Plc; the University of Manchester to develop immune-supporting microbiome formulations; and Winclove Probiotics B.V. for the development of a probiotic blend of good bacterial strains based on the modifying properties of specific bacterial species in known psoriasis pathways. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Visit WebsiteEarnings History & Surprises
SBTX.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 24, 2026 | — | — | — | — |
Q4 2025 | Dec 5, 2025 | — | $0.00 | — | — |
Q1 2025 | Mar 27, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 28, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 22, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 29, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 28, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 15, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.00 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.00 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.01 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about SBTX.L
What is SBTX.L's current stock price?
What is the analyst price target for SBTX.L?
What sector is SkinBioTherapeutics Plc in?
What is SBTX.L's market cap?
Does SBTX.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SBTX.L for comparison